Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CaptBeer
Yet another reason for the 10 % drop for us When will it ever end ? I mean OMG we cannot even be at 1 dollar so sad . Less then 2 million shares traded what happens when its 40/50 million shares ?
Michael
EPA is a med that needs development ASAP, not only for the CVD indication, but also for several other indications...If Amarin is unable to perform this task, Amarin should be sold to a BP that has the necessary assets to do it.
My apologies for my mistake. I was looking at JAMA Network link, not the link you had referred to.
JR, You are an Ok guy 'some days' - when your not focusing on Sarissa and Denner 'cheating everyone' in the market 🙂
---------------------------------
Here trying to solve the confusion - olive oil / EPA Vascepa for North - 'no spring hare' !
Capt. What would you have AMRN do with this info ?
AMRN doesn't have any patents covering composition or method of action for treating migraines that I'm aware of .
The trial was run using Epadel ...and it only enrolled 70 people using a drug not FDA regulated
ralphey, You seriously are in need of psychological help.
You spending time on a random financial forum - where you clearly have no idea of what is actually going on - calls for a serios mental problem !
--------------------------------
You go find a qualified psychiatrist - who know which best drugs to help you - and in a few months - you will again be able to appreciate being alive 🙂
Captain, Let me know if you get a response.
Thanks.
Sleven,
yep. I sent this link and my slides to Amarin. They need to get eyes on this. The CRC study is another one that they need to move on.
Captain,
https://www.sciencedirect.com/science/article/pii/S0889159124003003
Journal publication.
Sleven,
The Treatment Arm consisted of:
(2) 1g capsules of EPA (900mg), DHA (10mg), other FA's (90mg) * note although not specifically named this is the formulation of EPADEL.
The Placebo Arm was 100% Soybean Oil
DYK that EPA significantly reduces the number of migraine attacks and their severity. Who knew?https://t.co/SLwMWHqegK
— Mike Everts (@GeoWizz_) May 8, 2024
@Amarincorp @SABOURETCardio @DLBHATTMD @drpablocorral @mmillermd1 @VietHeartPA @MarkBrady2014 pic.twitter.com/tSz3wGPuMr
CCI.
Clown contrarian indicator
Yeah, what’s with the beat down today?
Ralphey,
You are bitter. We are all sad and disappointed, but it serves no purpose to get bitter.
Looks like everyone that wanted a lower PPS is Happy Happy Happy !!!
Michael
Probably. Thanks.
He may be looking at the study that I posted, which WAS referring to a study on olive oil consumption and dementia
Capt clearly states EPA in his message and accompanying chart. Olive oil is not mentioned.
I see no mention of Epadol in my print of study, only olive oil.
North, I believe it is 1.8 gr of EPADEL EPA per day, not olive oil.
Nice graph summarizing the benefits of 1.8 grams of olive oil per day, or maybe 2 capsules of (more?) expensive Vascepa per day. I have been taking unknown weights of olive oil for much longer than 4 grams of V per day. What would Chinese citizens be persuaded to take?
Over 1 billion people worldwide suffer from migraines. A new trial completed in Taiwan using 1.8g EPA/day vs. placebo demonstrated significant improvement in frequency of attacks and in the severity of those events. Another huge potential Indication for VASCEPA/VAZKEPA.
Here's a summary slide I put together showing the Primary Outcome Measures:
Too good to be true ! AMRN that wonderful soap opera . AS you will recall the stock was $1 in 2007. A lot has happened since then . The desperate housewives were jilted by the loser Thero who absconded with all of their money. They fell in love with AMRN who repeatedly pumped and dumped them yet they always come back for more. The fat lady is singing but the pudding is no longer mud. Its pink ! Yes Momma gonna make PINK SHEET PUDDING ! Drum Roll Paaaaleeeeze ta dum tad dum ta dum BOOM Thats right the stock is worth 94 pennies less than what it was in 2007 !! Tune in next week for the same story line as the desperate housewives of Investors hub get pumped and dumped all along screaming that its a wonderful buying opportunity !!
I realize this is comparing apples to oranges, however, it has to lead one to wonder if olive oil uses some of the same pathways as EPA.
This was a VERY long study (observational) - 28 years. Which also helps support the belief that a very long-term study on EPA consumption would lead to very positive ALZ outcomes.
I hope Denner will use it to interest a BP in using Vascepa as an adjunct drug for all cancer
treatments or therapies.
quite a lot actually. I loaded up on the Friday morning prior to the R-It announcement. I was in a buy and hold mode until the false upside FDA announcement breakout. I then became a trader. I've never shorted the stock. I only traded reaction counter-trend pullups to falling resistance. I was on the sidelines for the Du announcement.
R-IT entry
I am in love with IPE but my TA trumps that love affair... always!
Then you must have traded very successfully on those two major events..... do tell how much profit that you pocketed .
Most of you know that the results from the PREPARE RCT (PRevention Using EPA Against coloREctal) was released last week at: https://clinicaltrials.gov/study/NCT04216251
Personal communication with the PI informed me that a peer reviewed publication would be forthcoming before year end. In the meantime, I prepared this slide to illustrate the Primary Outcome Measure: Change in the Marine Omega-3 Polyunsaturated Fatty Acid (MO3PUFA) Composition in Colorectal Tissues as a Result of the AMR101 (VASCEPA) Treatment. [Time Frame: 8-12 weeks]
It is believed that EPA acts as a “chemopreventive” agent to reduce the risk of CRC in patients with a history of CRC. These results look impressive to me. I guess we’ll wait for the expert’s opinions.
Really? LOL. Then you failed to read my post.
FFS, you are starting to lose some credibility if you fail to admit that what you have highlighted did not predict what was to come, these strong moves occurred after the news, then a new pattern developed as a result of the new trading norms.
SND, just because he might have different thoughts about how to use $50M, doesn't mean he doesn't want to make money in the stock.
I have not been a huge Denner supporter, but I still want Amarin to do well, want Denner to do well, and for me to make money.
If they are going to do the buyback regardless, then he's obviously going to hope for the best outcome.
These ideas are not mutually exclusive.
Ramfan, again, IMO you are wrong.
FFS, the point I'm making is that of timing.... first let me say, I'm a fan of your technicals but I also know a signal of say bouncing off a top because it couldn't break through, could be smashed through a day later with unexpected news such as a REDUCE-It result or a Du ruling.... the technicals do not see that coming. That is unless there is a leak which can show in the technicals
Wow !!! I am speechless. The person who is so against Amarin’s move to buy back 50M worth of share and has been constantly beating the drum voicing his strong opposition to this move by the management, has bought share with the sole hope of UK court approving the buy back ( the only catalyst) he can see.
Wow !!! That definitely goes a long way to build credibility and expecting people believe in your ridiculous theory of using the buy-back money to run another trial for Germany, France and Italy.
Really ???
FFS. re this post
Ramfan, how so? Please explain
good or bad news simply moves prices to extreme edges; a place where very profitable trades happen.
good news can elevate a stock price to overbought levels in a hurry. If unsupported by volume, those prices quickly meet supply and a retracement ensues.
Bad news can produce a mirror image of the above.
TA is very good at sorting out synchronization between technical and fundamental strength. Its even better at identifying bullish or bearish divergences between the two - which lead to squeeze reversals.
So no, respectfully (IMO), your statement is 180 wrong.
must keep my statements in context Rosie. I did not predict "new lows". I predicted a new yearly low (read the linked post again).
The yearly low at the time was .8015/ share. Since my post the stock has traced a low of .8110, less than 1 cent from the yearly low. I was wrong by a penny LOL.
Yes, technicals are good to use as trade indicators but any news good or bad will throw them out of whack for a time so it's best to pair fundamentals with technicals to get the best picture.
No argument there and fly fishing obviously has considerable knowledge of TA, but when hundreds of predictions are made you can easily pick and choose which look prescient. Can’t remember exactly and I am on a cruise ship without much access but I think Fly got screwed on his prediction for new lows as Amarin came out with news that obviated his call, or at least the reaction to the news.
That's a fairly sober and seemingly accurate post of prospects, except for "Reversal of the Du-saster." That cannot happen. Appeals process is long over.
Thanks for the clarification.
rosemontbomber
I think we did go down to .85 which has to be close to the low before turning up to today's price. Just saying.
Michael
I think there are a number of reasons for a lack of BP BO interest in AMRN…
On-going litigation
Slow sales growth
Negative EPS
Price erosion in U.S.
Perceived inability to get a return on investment
Tight credit conditions
No clinical trials to support better outcomes in cancer patients
It’s not yet for sale. (Kind of the same theory behind why you wash your car before you trade it in for a new one).
With that, brighter days could be in AMRN’s future…
Expanding to additional EU markets
+EPS
Share Buyback
Brave study results
Reversal of the Du-saster
Easing of credit conditions
Etc…
I feel it will remain over a dollar for a couple of days and then will again go below dollar. This looks more like an orchestrated rise to one dollar to avoid the delisting formality from kicking in. The real rise will be much faster with lots of volume.
I am not done with buying, so won’t be sad if it comes below the dollar again. If it does not then also no complain. I have enough in the game for this ticker already.
Do you mean his post at end of April or the one a couple of weeks prior that predicted new lows?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174266900
JRoon71
May close over the 1$ threshold today looks like flyfishingstocks was right !
Michael
You choose whether you want to sell AMRN at Rolls Royce price or Toyota price.
Patents aren't exclusivity. Regulatory Exclusivity is a government issued monopoly for a period of time to reward drug development. Patents are only as good as your legal team as any Amarin investor should know.
I think the EU patent is now good till 2039 whereas the current US patent is good till 2029.
Nah. You only get one "+1" extension with the EMA and it has to be filed and approved in the initial 8 year data exclusivity window. The system is designed to stop drug companies from doing what you describe... issue endless minor indications to try and lock up exclusivity forever. They want generics on the market.
Followers
|
1109
|
Posters
|
|
Posts (Today)
|
12
|
Posts (Total)
|
429109
|
Created
|
03/12/07
|
Type
|
Free
|
Moderators ziploc_1 zmanindc Number sleven |
AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote
Y! Finance AMRN Landing Page
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |